Viking Therapeutics, Inc. (VKTX)
32.28
+0.97
(+3.10%)
USD |
NASDAQ |
May 06, 16:00
32.17
-0.11
(-0.34%)
After-Hours: 07:06
Viking Therapeutics SG&A Expense (TTM) : 48.28M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Amgen, Inc. | 6.965B |
| Hims & Hers Health, Inc. | 1.192B |
| Structure Therapeutics, Inc. | 61.72M |
| Pfizer Inc. | 10.76B |